AC
WST icon

Allstate Corporation’s West Pharmaceutical WST Stock Holding History

Allstate Corporation’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42M Buy
9,536
+127
+1% +$38.8K 0.03% 305
2026
Q1 		$2.36M Buy
9,409
+4,144
+79% +$1.03M 0.03% 455
2025
Q4 		$1.45M Buy
5,265
+2,694
+105% +$737K 0.02% 448
2025
Q3 		$674K Buy
+2,571
New +$625K 0.02% 457
2025
Q2 		– Sell
-3,228
Closed -$723K – 567
2025
Q1 		$723K Buy
3,228
+1,072
+50% +$295K 0.02% 424
2024
Q4 		$706K Buy
+2,156
New +$679K 0.02% 392
2023
Q1 		– Sell
-4,217
Closed -$992K – 555
2022
Q4 		$992K Sell
4,217
-149
-3% -$35.3K 0.03% 353
2022
Q3 		$1.07M Buy
4,366
+418
+11% +$127K 0.03% 314
2022
Q2 		$1.19M Sell
3,948
-623
-14% -$203K 0.04% 293
2022
Q1 		$1.88M Buy
+4,571
New +$1.79M 0.05% 264
2020
Q4 		– Sell
-2,134
Closed -$586K – 723
2020
Q3 		$586K Sell
2,134
-4,327
-67% -$1.15M 0.02% 363
2020
Q2 		$1.47M Sell
6,461
-53
-0.8% -$10.4K 0.05% 180
2020
Q1 		$992K Sell
6,514
-992
-13% -$153K 0.04% 216
2019
Q4 		$1.13M Buy
+7,506
New +$1.09M 0.02% 410

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Allstate Corporation's WST Position: Q2 2026 in Review

Allstate Corporation increased its West Pharmaceutical (WST) stake by 1.3% in Q2 2026, buying an estimated $38.8K and bringing the position to 9,536 shares worth $3.42M. The position accounts for 0.03% of the portfolio, ranked #305.

Allstate Corporation first reported a position in WST in Q4 2019 and has held it in 14 quarters since. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Allstate Corporation held 9,536 shares of West Pharmaceutical worth $3.42M as of Q2 2026.
  • Allstate Corporation bought 127 West Pharmaceutical shares in Q2 2026, an estimated $38.8K.
  • West Pharmaceutical made up 0.03% of Allstate Corporation's portfolio in Q2 2026, its #305 holding.
  • Allstate Corporation first reported a position in West Pharmaceutical in Q4 2019 and has held it in 14 quarters since.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.